Help us caption and translate this video on Amara.org: http://www.amara.org/en/v/B5Eh/ Introduction to benzodiazepines and barbiturates. Covering definitions of sedative, hypnotic, naming conventions as well as a refresher on Dose-response curves including competitive inhibitors and allosteric activators. Next Video: The GABA Receptor – How does it work http://www.youtube.com/watch?v=-eBUJ-1vcjk Learn pharmacology with my other videos below: (1) Pharmacokinetics & ADME: http://youtu.be/CMRZqdrkCZw DRUG ABSORPTION Videos: (2) Drug Absorption Overview: http://youtu.be/eya9jR3v7i8 (3) Bioavailability: http://youtu.be/rv2Rpdi7OHM DRUG DISTRIBUTION Videos: (4) Drug Distribution Overview: http://youtu.be/DH2WGUd7MBs (5) Volume of Distribution: http://youtu.be/B63sqUfvFQQ —————— DRUG METABOLISM Videos: (6) First Pass Metabolism: http://youtu.be/5AB8WkCbz4k (7) Phase I Metabolism: http://youtu.be/GGLddVpVg9M (8) Phase II Metabolism: http://youtu.be/iIWAUo05GFE (9) First Order and Zero Order Kinetics: http://youtu.be/XEotDfKhNTw (10) Drug Half-life: http://youtu.be/eTqPsqnbwoc (11) First-order elimination rate constant and half-life-details: http://youtu.be/De9999Jj-5Q —————————————— DRUG ELIMINATION / EXCRETION (12) Drug Clearance: http://youtu.be/csywV3MYHDg (13) Renal Excretion of Drugs: http://youtu.be/8c3gqI6R-Vw (14) Ion Trapping: [not yet posted] (15) Dosage Regimens: [not yet posted] ——————————————————————— Factors That Affect Drug Metabolism: (16) Enzyme Induction: http://youtu.be/Dtbkc8F_ff0 (17) Competitive Inhibition Overview: http://youtu.be/iNIxMuHuL3w (18) Competitive Inhibition of Statins: http://youtu.be/Lt1-mjMFniE (19) Acetaminophen toxicity (Clinical Correlate): [Not yet posted] (20) Pharmacogenomics Overview: http://youtu.be/3vZxbX5P9TU (21) Slow Acetylators – Pharmacogenomics: [not yet posted] Help us caption & translate this video! http://amara.org/v/B5Eh/
Sedative Hypnotics, Benzodiazepines and Barbiturates –
- Post author:
- Post published:May 25, 2021
- Post category:Uncategorized
- Post comments:0 Comments